Automated peritoneal dialysis - indications and management

Area of Science:

• Nephrology
• Renal Replacement Therapy

Background:

• Increased utilization of Automated Peritoneal Dialysis (APD) over the past decade.
• Growth driven by patient preference and advancements in simpler cycler technology.
• APD management can achieve adequate solute and fluid removal for most patients.

Purpose of the Study:

• To evaluate the efficacy and patient-centered benefits of Automated Peritoneal Dialysis (APD).
• To compare APD outcomes with Continuous Ambulatory Peritoneal Dialysis (CAPD).

Main Methods:

• Review of existing data comparing APD and CAPD.
• Analysis of patient preference and technological advancements in APD cyclers.
• Assessment of solute and fluid removal capabilities with APD prescription management.

Main Results:

• No convincing data shows significant differences in peritonitis rates, renal function decline, protein loss, or survival between APD and CAPD.
• APD prescription management ensures adequate treatment for a wide range of patients, including anuric and larger individuals.
• APD demonstrates a major advantage in improving the lifestyle of end-stage renal disease patients.

Conclusions:

• Automated Peritoneal Dialysis (APD) is a viable and effective treatment option for end-stage renal disease.
• APD offers comparable clinical outcomes to Continuous Ambulatory Peritoneal Dialysis (CAPD).
• The primary benefit of APD lies in its potential to positively impact patient lifestyle.